# Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)

> **NCT00810121** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 409 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ketoprofen 100 mg
- **DRUG:** ketoprofen

## Key facts

- **NCT ID:** NCT00810121
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2009-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810121, "Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00810121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*